Galvin Gaustad & Stein’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $10.2M | Buy |
22,890
+1,529
| +7% | +$681K | 0.88% | 49 |
|
|
2025
Q1 | $10.4M | Sell |
21,361
-367
| -2% | -$178K | 0.93% | 48 |
|
|
2024
Q4 | $8.75M | Sell |
21,728
-233
| -1% | -$93.8K | 0.78% | 52 |
|
|
2024
Q3 | $10.2M | Sell |
21,961
-14,724
| -40% | -$6.85M | 0.91% | 45 |
|
|
2024
Q2 | $17.2M | Buy |
36,685
+9,280
| +34% | +$4.35M | 1.6% | 27 |
|
|
2024
Q1 | $11.5M | Buy |
27,405
+6,358
| +30% | +$2.66M | 1.05% | 41 |
|
|
2023
Q4 | $8.56M | Buy |
+21,047
| New | +$8.56M | 0.8% | 46 |
|